Insys Therapeutics leaps following earnings beat

Insys (INSY +21%) jumps after Q4 results beat consensus.

Insys swings to a net profit of $24.1M from a loss of $7.1M a year earlier.

Sales of Subsys +38% on quarter to $39.2M.

Shares are up a whopping eight-fold from Insys' IPO price of $8 on May 2.

The company didn't provide guidance in its PR but analysts expect EPS of $0.48 in Q1 and $2.02 in 2014.

Mutual fund ownership has skyrocketed from 1 to 143 in the past 4 quarters. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs